Britannia Life Sciences Statistics

Total Valuation

CSE:BLAB has a market cap or net worth of CAD 11.36 million. The enterprise value is 5.37 million.

Market Cap	11.36M
Enterprise Value	5.37M

Important Dates

The last earnings date was Tuesday, July 29, 2025.

Earnings Date	Jul 29, 2025
Ex-Dividend Date	n/a

Share Statistics

CSE:BLAB has 162.25 million shares outstanding.

Current Share Class	162.25M
Shares Outstanding	162.25M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	36.78%
Owned by Institutions (%)	0.93%
Float	102.58M

Valuation Ratios

The trailing PE ratio is 1.54.

PE Ratio	1.54
Forward PE	n/a
PS Ratio	30.76
PB Ratio	1.80
P/TBV Ratio	1.80
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	0.73
EV / Sales	14.53
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.72, with a Debt / Equity ratio of 0.29.

Current Ratio	2.72
Quick Ratio	2.21
Debt / Equity	0.29
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-20.87

Financial Efficiency

Return on equity (ROE) is -70.32% and return on invested capital (ROIC) is -12.52%.

Return on Equity (ROE)	-70.32%
Return on Assets (ROA)	-8.18%
Return on Invested Capital (ROIC)	-12.52%
Return on Capital Employed (ROCE)	-27.84%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +40.00% in the last 52 weeks. The beta is -0.03, so CSE:BLAB's price volatility has been lower than the market average.

Beta (5Y)	-0.03
52-Week Price Change	+40.00%
50-Day Moving Average	0.07
200-Day Moving Average	0.07
Relative Strength Index (RSI)	42.39
Average Volume (20 Days)	164,315

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CSE:BLAB had revenue of CAD 369,279 and earned 7.39 million in profits. Earnings per share was 0.05.

Revenue	369,279
Gross Profit	27,328
Operating Income	-2.22M
Pretax Income	-4.56M
Net Income	7.39M
EBITDA	-2.11M
EBIT	-2.22M
Earnings Per Share (EPS)	0.05

Full Income Statement

Balance Sheet

The company has 7.85 million in cash and 1.86 million in debt, giving a net cash position of 5.99 million or 0.04 per share.

Cash & Cash Equivalents	7.85M
Total Debt	1.86M
Net Cash	5.99M
Net Cash Per Share	0.04
Equity (Book Value)	6.30M
Book Value Per Share	0.04
Working Capital	6.27M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-2.62M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 7.40%, with operating and profit margins of -599.97% and 2,001.95%.

Gross Margin	7.40%
Operating Margin	-599.97%
Pretax Margin	-1,235.00%
Profit Margin	2,001.95%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CSE:BLAB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	65.09%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on November 18, 2021. It was a reverse split with a ratio of 0.1.

Last Split Date	Nov 18, 2021
Split Type	Reverse
Split Ratio	0.1

Scores

CSE:BLAB has an Altman Z-Score of -0.4 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.4
Piotroski F-Score	3